Worldwide, roughly 10,000 affected children nicknamed «thalidomide babies» were born with multiple defects, including the characteristic shortened upper limbs (a condition known
as phocomelia, Greek for «seal limbs»), before the drug was discontinued in 1961 after four years on the market.
Conventional wisdom has long held that thalidomide's signature defect — a shortened, seal - like «flapper» arm, known
as phocomelia — affects both sides of the body.
Not exact matches
Doses
as low
as 54 milligrams in an average - sized adult female (far less than a quarter of a teaspoon) can cause an increased risk of
phocomelia — a decrease in the size of the upper limbs.